HEADER HYDROLASE/HYDROLASE INHIBITOR 07-SEP-17 6AY2 TITLE STRUCTURE OF CATHB WITH COVALENTLY LINKED COMPOUND 28 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATHEPSIN B; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: APP SECRETASE, APPS, CATHEPSIN B1; COMPND 5 EC: 3.4.22.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CTSB, CPSB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEASE, COVALENT, INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.R.KIEFER,S.STEINBACHER REVDAT 2 21-FEB-18 6AY2 1 JRNL REVDAT 1 27-DEC-17 6AY2 0 JRNL AUTH B.WEI,J.GUNZNER-TOSTE,H.YAO,T.WANG,J.WANG,Z.XU,J.CHEN,J.WAI, JRNL AUTH 2 J.NONOMIYA,S.P.TSAI,J.CHUH,K.R.KOZAK,Y.LIU,S.F.YU,J.LAU, JRNL AUTH 3 G.LI,G.D.PHILLIPS,D.LEIPOLD,A.KAMATH,D.SU,K.XU,C.EIGENBROT, JRNL AUTH 4 S.STEINBACHER,R.OHRI,H.RAAB,L.R.STABEN,G.ZHAO,J.A.FLYGARE, JRNL AUTH 5 T.H.PILLOW,V.VERMA,L.A.MASTERSON,P.W.HOWARD,B.SAFINA JRNL TITL DISCOVERY OF PEPTIDOMIMETIC ANTIBODY-DRUG CONJUGATE LINKERS JRNL TITL 2 WITH ENHANCED PROTEASE SPECIFICITY. JRNL REF J. MED. CHEM. V. 61 989 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 29227683 JRNL DOI 10.1021/ACS.JMEDCHEM.7B01430 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.54 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 65070 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.162 REMARK 3 R VALUE (WORKING SET) : 0.161 REMARK 3 FREE R VALUE : 0.177 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.600 REMARK 3 FREE R VALUE TEST SET COUNT : 3826 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3911 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 237 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.31 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.12000 REMARK 3 B22 (A**2) : 4.32000 REMARK 3 B33 (A**2) : -8.44000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.59000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.016 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.015 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.044 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.266 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 6AY2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-SEP-17. REMARK 100 THE DEPOSITION ID IS D_1000229988. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-MAY-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X1A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98764 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 68898 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 46.540 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 2.896 REMARK 200 R MERGE (I) : 0.04100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.2700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.87 REMARK 200 R MERGE FOR SHELL (I) : 0.17800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.070 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AS PUBLISHED, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 63.62150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS B 0 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ASP A 69 CG OD1 OD2 REMARK 480 GLU A 194 CG CD OE1 OE2 REMARK 480 ASP B 69 CG OD1 OD2 REMARK 480 LYS B 127 CG CD CE NZ REMARK 480 LYS B 158 CG CD CE NZ REMARK 480 LYS B 184 CE NZ REMARK 480 ASP B 254 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU B 122 N22 C1G B 301 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ASP A 69 CB ASP A 69 CG 0.408 REMARK 500 ASP B 69 CB ASP B 69 CG 0.178 REMARK 500 LYS B 184 CD LYS B 184 CE 0.298 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 69 CA - CB - CG ANGL. DEV. = -18.4 DEGREES REMARK 500 ASP A 69 CB - CG - OD1 ANGL. DEV. = 11.4 DEGREES REMARK 500 ASP A 69 CB - CG - OD2 ANGL. DEV. = -10.9 DEGREES REMARK 500 ASP B 69 CB - CG - OD1 ANGL. DEV. = 9.7 DEGREES REMARK 500 ASP B 69 CB - CG - OD2 ANGL. DEV. = -9.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 138 -159.32 -81.65 REMARK 500 ASN A 222 175.15 71.42 REMARK 500 GLU A 245 44.15 -140.06 REMARK 500 GLU B 122 87.55 47.66 REMARK 500 LYS B 184 -43.01 -130.02 REMARK 500 ASN B 222 174.29 72.89 REMARK 500 ASP B 238 49.34 39.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 C1G A 301 REMARK 615 C1G B 301 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue C1G A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue C1G B 301 DBREF 6AY2 A 0 254 UNP P07858 CATB_HUMAN 79 333 DBREF 6AY2 B 0 254 UNP P07858 CATB_HUMAN 79 333 SEQRES 1 A 255 LYS LEU PRO ALA SER PHE ASP ALA ARG GLU GLN TRP PRO SEQRES 2 A 255 GLN CYS PRO THR ILE LYS GLU ILE ARG ASP GLN GLY SER SEQRES 3 A 255 CYS GLY SER CYS TRP ALA PHE GLY ALA VAL GLU ALA ILE SEQRES 4 A 255 SER ASP ARG ILE CYS ILE HIS THR ASN ALA HIS VAL SER SEQRES 5 A 255 VAL GLU VAL SER ALA GLU ASP LEU LEU THR CYS CYS GLY SEQRES 6 A 255 SER MET CYS GLY ASP GLY CYS ASN GLY GLY TYR PRO ALA SEQRES 7 A 255 GLU ALA TRP ASN PHE TRP THR ARG LYS GLY LEU VAL SER SEQRES 8 A 255 GLY GLY LEU TYR GLU SER HIS VAL GLY CYS ARG PRO TYR SEQRES 9 A 255 SER ILE PRO PRO CYS GLU HIS HIS VAL ASN GLY SER ARG SEQRES 10 A 255 PRO PRO CYS THR GLY GLU GLY ASP THR PRO LYS CYS SER SEQRES 11 A 255 LYS ILE CYS GLU PRO GLY TYR SER PRO THR TYR LYS GLN SEQRES 12 A 255 ASP LYS HIS TYR GLY TYR ASN SER TYR SER VAL SER ASN SEQRES 13 A 255 SER GLU LYS ASP ILE MET ALA GLU ILE TYR LYS ASN GLY SEQRES 14 A 255 PRO VAL GLU GLY ALA PHE SER VAL TYR SER ASP PHE LEU SEQRES 15 A 255 LEU TYR LYS SER GLY VAL TYR GLN HIS VAL THR GLY GLU SEQRES 16 A 255 MET MET GLY GLY HIS ALA ILE ARG ILE LEU GLY TRP GLY SEQRES 17 A 255 VAL GLU ASN GLY THR PRO TYR TRP LEU VAL ALA ASN SER SEQRES 18 A 255 TRP ASN THR ASP TRP GLY ASP ASN GLY PHE PHE LYS ILE SEQRES 19 A 255 LEU ARG GLY GLN ASP HIS CYS GLY ILE GLU SER GLU VAL SEQRES 20 A 255 VAL ALA GLY ILE PRO ARG THR ASP SEQRES 1 B 255 LYS LEU PRO ALA SER PHE ASP ALA ARG GLU GLN TRP PRO SEQRES 2 B 255 GLN CYS PRO THR ILE LYS GLU ILE ARG ASP GLN GLY SER SEQRES 3 B 255 CYS GLY SER CYS TRP ALA PHE GLY ALA VAL GLU ALA ILE SEQRES 4 B 255 SER ASP ARG ILE CYS ILE HIS THR ASN ALA HIS VAL SER SEQRES 5 B 255 VAL GLU VAL SER ALA GLU ASP LEU LEU THR CYS CYS GLY SEQRES 6 B 255 SER MET CYS GLY ASP GLY CYS ASN GLY GLY TYR PRO ALA SEQRES 7 B 255 GLU ALA TRP ASN PHE TRP THR ARG LYS GLY LEU VAL SER SEQRES 8 B 255 GLY GLY LEU TYR GLU SER HIS VAL GLY CYS ARG PRO TYR SEQRES 9 B 255 SER ILE PRO PRO CYS GLU HIS HIS VAL ASN GLY SER ARG SEQRES 10 B 255 PRO PRO CYS THR GLY GLU GLY ASP THR PRO LYS CYS SER SEQRES 11 B 255 LYS ILE CYS GLU PRO GLY TYR SER PRO THR TYR LYS GLN SEQRES 12 B 255 ASP LYS HIS TYR GLY TYR ASN SER TYR SER VAL SER ASN SEQRES 13 B 255 SER GLU LYS ASP ILE MET ALA GLU ILE TYR LYS ASN GLY SEQRES 14 B 255 PRO VAL GLU GLY ALA PHE SER VAL TYR SER ASP PHE LEU SEQRES 15 B 255 LEU TYR LYS SER GLY VAL TYR GLN HIS VAL THR GLY GLU SEQRES 16 B 255 MET MET GLY GLY HIS ALA ILE ARG ILE LEU GLY TRP GLY SEQRES 17 B 255 VAL GLU ASN GLY THR PRO TYR TRP LEU VAL ALA ASN SER SEQRES 18 B 255 TRP ASN THR ASP TRP GLY ASP ASN GLY PHE PHE LYS ILE SEQRES 19 B 255 LEU ARG GLY GLN ASP HIS CYS GLY ILE GLU SER GLU VAL SEQRES 20 B 255 VAL ALA GLY ILE PRO ARG THR ASP HET C1G A 301 27 HET C1G B 301 27 HETNAM C1G N~1~-[(2S)-1-AMINO-5-(CARBAMOYLAMINO)PENTAN-2-YL]- HETNAM 2 C1G N'~1~-[(1R)-1-(THIOPHEN-3-YL)ETHYL]CYCLOBUTANE-1,1- HETNAM 3 C1G DICARBOXAMIDE FORMUL 3 C1G 2(C18 H29 N5 O3 S) FORMUL 5 HOH *237(H2 O) HELIX 1 AA1 ALA A 7 TRP A 11 1 5 HELIX 2 AA2 CYS A 14 GLU A 19 5 6 HELIX 3 AA3 SER A 28 THR A 46 1 19 HELIX 4 AA4 SER A 55 CYS A 63 1 9 HELIX 5 AA5 GLY A 64 CYS A 67 5 4 HELIX 6 AA6 ASP A 69 GLY A 73 5 5 HELIX 7 AA7 TYR A 75 LYS A 86 1 12 HELIX 8 AA8 TYR A 140 LYS A 144 5 5 HELIX 9 AA9 SER A 156 GLY A 168 1 13 HELIX 10 AB1 ASP A 179 TYR A 183 5 5 HELIX 11 AB2 ASP A 238 ILE A 242 5 5 HELIX 12 AB3 ALA B 7 TRP B 11 1 5 HELIX 13 AB4 CYS B 14 GLU B 19 5 6 HELIX 14 AB5 SER B 28 THR B 46 1 19 HELIX 15 AB6 SER B 55 CYS B 63 1 9 HELIX 16 AB7 GLY B 64 CYS B 67 5 4 HELIX 17 AB8 ASP B 69 GLY B 73 5 5 HELIX 18 AB9 TYR B 75 LYS B 86 1 12 HELIX 19 AC1 SER B 156 GLY B 168 1 13 HELIX 20 AC2 ASP B 179 TYR B 183 5 5 HELIX 21 AC3 ASP B 238 ILE B 242 5 5 SHEET 1 AA1 3 PHE A 5 ASP A 6 0 SHEET 2 AA1 3 MET A 195 GLU A 209 -1 O TRP A 206 N PHE A 5 SHEET 3 AA1 3 VAL A 170 TYR A 177 -1 N VAL A 176 O MET A 196 SHEET 1 AA2 5 PHE A 5 ASP A 6 0 SHEET 2 AA2 5 MET A 195 GLU A 209 -1 O TRP A 206 N PHE A 5 SHEET 3 AA2 5 THR A 212 ALA A 218 -1 O ALA A 218 N ARG A 202 SHEET 4 AA2 5 PHE A 230 LEU A 234 -1 O PHE A 231 N VAL A 217 SHEET 5 AA2 5 VAL A 187 TYR A 188 1 N TYR A 188 O LYS A 232 SHEET 1 AA3 2 TYR A 151 SER A 152 0 SHEET 2 AA3 2 VAL A 247 ALA A 248 -1 O ALA A 248 N TYR A 151 SHEET 1 AA4 3 PHE B 5 ASP B 6 0 SHEET 2 AA4 3 MET B 195 GLU B 209 -1 O TRP B 206 N PHE B 5 SHEET 3 AA4 3 VAL B 170 TYR B 177 -1 N VAL B 176 O MET B 196 SHEET 1 AA5 5 PHE B 5 ASP B 6 0 SHEET 2 AA5 5 MET B 195 GLU B 209 -1 O TRP B 206 N PHE B 5 SHEET 3 AA5 5 THR B 212 ALA B 218 -1 O ALA B 218 N ARG B 202 SHEET 4 AA5 5 PHE B 230 LEU B 234 -1 O PHE B 231 N VAL B 217 SHEET 5 AA5 5 VAL B 187 TYR B 188 1 N TYR B 188 O LYS B 232 SHEET 1 AA6 2 TYR B 151 SER B 152 0 SHEET 2 AA6 2 VAL B 247 ALA B 248 -1 O ALA B 248 N TYR B 151 SSBOND 1 CYS A 14 CYS A 43 1555 1555 2.05 SSBOND 2 CYS A 26 CYS A 71 1555 1555 2.04 SSBOND 3 CYS A 62 CYS A 128 1555 1555 2.04 SSBOND 4 CYS A 63 CYS A 67 1555 1555 2.02 SSBOND 5 CYS A 100 CYS A 132 1555 1555 2.03 SSBOND 6 CYS A 108 CYS A 119 1555 1555 2.03 SSBOND 7 CYS B 14 CYS B 43 1555 1555 2.06 SSBOND 8 CYS B 26 CYS B 71 1555 1555 2.03 SSBOND 9 CYS B 62 CYS B 128 1555 1555 2.04 SSBOND 10 CYS B 63 CYS B 67 1555 1555 2.02 SSBOND 11 CYS B 100 CYS B 132 1555 1555 2.03 SSBOND 12 CYS B 108 CYS B 119 1555 1555 2.02 LINK SG CYS A 29 C26 C1G A 301 1555 1555 1.74 LINK SG CYS B 29 C26 C1G B 301 1555 1555 1.73 CISPEP 1 SER A 137 PRO A 138 0 1.44 CISPEP 2 SER B 137 PRO B 138 0 4.67 SITE 1 AC1 9 GLN A 23 GLY A 27 CYS A 29 TRP A 30 SITE 2 AC1 9 GLY A 73 GLY A 74 GLY A 198 HIS A 199 SITE 3 AC1 9 THR A 223 SITE 1 AC2 14 GLN B 23 GLY B 27 SER B 28 TRP B 30 SITE 2 AC2 14 ALA B 31 PHE B 32 GLY B 33 GLY B 73 SITE 3 AC2 14 GLY B 74 PRO B 76 GLY B 198 HIS B 199 SITE 4 AC2 14 ALA B 200 THR B 223 CRYST1 31.317 127.243 70.034 90.00 102.90 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.031932 0.000000 0.007315 0.00000 SCALE2 0.000000 0.007859 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014649 0.00000